Publications

Detailed Information

Lysophosphatidic acid-induced changes in cAMP profiles in young and senescent human fibroblasts as a clue to the ageing process

DC Field Value Language
dc.contributor.authorJang, Ik-Soon-
dc.contributor.authorRhim, Ji-Heon-
dc.contributor.authorKim, Kyung-Tae-
dc.contributor.authorCho, Kyung A.-
dc.contributor.authorYeo, Eui-Ju-
dc.contributor.authorPark, Sang Chul-
dc.date.accessioned2010-01-08T08:49:41Z-
dc.date.available2010-01-08T08:49:41Z-
dc.date.issued2006-03-07-
dc.identifier.citationMech Ageing Dev. 2006 May;127(5):481-9. Epub 2006 Mar 3.en
dc.identifier.issn0047-6374 (Print)-
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16516270-
dc.identifier.urihttps://hdl.handle.net/10371/29121-
dc.description.abstractThis study attempts to elucidate the molecular mechanisms underlying the ageing-dependent cAMP profiles in human diploid fibroblasts stimulated by lysophosphatidic acid (LPA). In senescent cells, LPA-dependent Gialpha activation was reduced, with a consequent reduction in Gi-suppressed cAMP levels, without alterations in the levels of Gialpha proteins. In young cells, when Gialpha activity was inhibited by pertussis toxin pretreatment, or when its expression was blocked by siRNA, the pattern of changes in cAMP levels in response to LPA was similar to that seen in senescent cells. An increase in protein kinase C (PKC)-dependent isoforms of adenylyl cyclase (AC) types II, IV, and VI was also observed in these senescent fibroblasts. In senescent cells treated with PKC-specific inhibitors, bis-indolylmaleimide, Go6976, rottlerin, and PKCvarepsilonV1, LPA-induced cAMP accumulation was inhibited, indicating that increased ACs in response to LPA occur via the activation of protein kinase Cs. When the expression of AC II, IV, and VI was blocked by siRNA in senescent fibroblasts, LPA-induced cAMP accumulation was also blocked. These results suggest that the senescence-associated increase of cAMP levels after LPA treatment is associated with reduced Gialpha, increased AC II, IV, and VI proteins, and PKC-dependent stimulation of their activities and provide an explanation for the age-dependent differences in cAMP-related physiological responses.en
dc.language.isoenen
dc.publisherElsevieren
dc.subjectAcetophenones/pharmacologyen
dc.subjectBenzopyrans/pharmacologyen
dc.subjectCarbazoles/pharmacologyen
dc.subjectCell Agingen
dc.subjectCell Lineen
dc.subjectCyclic AMP/*metabolismen
dc.subjectEnzyme Inhibitors/pharmacologyen
dc.subjectFibroblasts/*metabolismen
dc.subjectHumansen
dc.subjectIndoles/pharmacologyen
dc.subjectLysophospholipids/*metabolismen
dc.subjectRNA, Small Interfering/metabolismen
dc.subjectReceptors, Lysophosphatidic Acid/metabolismen
dc.subjectAging-
dc.titleLysophosphatidic acid-induced changes in cAMP profiles in young and senescent human fibroblasts as a clue to the ageing processen
dc.typeArticleen
dc.contributor.AlternativeAuthor장익순-
dc.contributor.AlternativeAuthor임지헌-
dc.contributor.AlternativeAuthor김경태-
dc.contributor.AlternativeAuthor조경아-
dc.contributor.AlternativeAuthor여의주-
dc.contributor.AlternativeAuthor박상철-
dc.identifier.doi10.1016/j.mad.2006.01.004-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share